Introduction to Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., headquartered in Hercules, California, stands as a global leader in life science research and clinical diagnostics. Established in 1952, the company has grown into a multi-billion dollar enterprise with operations spanning over 35 countries. With annual revenues exceeding $2.5 billion and a workforce of approximately 8,000 employees, Bio-Rad is renowned for its high-quality instruments, reagents, and software that serve academic institutions, hospitals, pharmaceutical companies, and industrial laboratories. The company’s reputation for excellence in healthcare is built on decades of innovation, particularly in areas such as digital PCR, Western blotting, and blood typing. Organizations worldwide rely on Bio-Rad’s solutions to advance scientific discovery, ensure food safety, and enhance clinical diagnostics.

Company History and Business Evolution

Bio-Rad was founded by David Schwartz and John R. M. Horn in 1952 with a focus on manufacturing specialty chemicals for laboratories. The company’s early milestones included the development of ion exchange resins and chromatography products, which revolutionized biochemical separation. In the 1970s, Bio-Rad expanded into clinical diagnostics with the acquisition of a line of blood coagulation tests. The 1980s and 1990s saw rapid growth through strategic acquisitions, including the purchase of Bio-Rad’s first monoclonal antibody facility. Innovations such as the first commercial Western blotting system and the introduction of digital PCR platforms solidified the company’s position as a technology leader. Today, Bio-Rad continues to evolve through partnerships and R&D investments, focusing on precision medicine and point-of-care diagnostics.

Bio-Rad Laboratories, Inc. at a Glance

• Headquarters: Hercules, California, USA
• Founded: 1952
• CEO: Norman Schwartz (current), with a legacy of family leadership
• Revenue: Approx. $2.5–2.8 billion annually
• Employees: 8,000+ globally
• Industry: Life Sciences & Clinical Diagnostics
• Key Products: QX200 Droplet Digital PCR system, Bio-Plex Multiplex Immunoassays, CFG-800 Automated Cell Counter
• Market Presence: Operations in 35+ countries
• Stock Symbol: BIO (NYSE)
• Research Focus: Cancer research, infectious disease, genetic testing
• Diagnostic Areas: Blood typing, diabetes monitoring, quality control
• Acquisitions: Bio-Rad acquired AbD Serotec, Exkemia, and other innovative firms
• Patents: Over 3,000 granted worldwide
• Manufacturing: Sites in USA, Europe, Asia
• Quality Standards: ISO 13485, FDA 510(k) clearances
• Community Engagement: Bio-Rad Foundation supports education and health
• Employee Recognition: Named a Best Place to Work by several publications
• Sustainability: Commitment to reducing carbon footprint by 2030
• Digital Transformation: Cloud-based data management for labs
• Global Service: 24/7 technical support and training

Mission, Vision, and Core Corporate Values

Bio-Rad’s mission is to provide innovative tools and services that accelerate scientific discovery and improve healthcare outcomes. The vision is to be the trusted partner for scientists and clinicians worldwide, delivering reliable, reproducible results. Core values include integrity, collaboration, customer focus, and continuous improvement. The company emphasizes diversity and inclusion as drivers of innovation, with employee resource groups supporting underrepresented communities. Ethical conduct and compliance with global regulations are non-negotiable, reinforced by rigorous training and audits. Sustainability goals, such as waste reduction and energy efficiency, reflect a commitment to environmental stewardship.

Business Strategy and Future Roadmap

Bio-Rad’s strategy centers on organic growth through R&D and strategic acquisitions to expand its portfolio in high-growth areas like liquid biopsy, single-cell analysis, and automation. The company plans to strengthen its presence in emerging markets such as India and China, where healthcare infrastructure is expanding. Digital transformation is a key focus, with investments in AI-driven data analytics and cloud platforms to enhance customer experience. Bio-Rad also aims to deepen partnerships with academic and industry leaders to co-develop next-generation diagnostic technologies. Future milestones include launching a new automated blood typing system and expanding the Droplet Digital PCR platform for clinical use. Financial stability and a strong balance sheet allow the company to weather market fluctuations and invest in long-term projects.

Products, Technologies, and Services

Bio-Rad offers a comprehensive range of products across two main segments: Life Science and Clinical Diagnostics. In Life Science, the flagship products include the QX200 Droplet Digital PCR system for absolute quantification of nucleic acids, the Bio-Plex 200 and 3D suspension array systems for multiplex protein analysis, and the ChemiDoc MP imaging system for gel documentation. The Clinical Diagnostics segment provides blood typing reagents (e.g., the IH‑1000 automated analyzer), diabetes monitoring (HbA1c testing), and quality control sera (Lyphochek). Additionally, Bio-Rad’s software solutions, such as the Bio-Rad CFG Manager for cell counting, integrate with laboratory information systems. The company also offers training, calibration, and repair services through its Global Service Network.

Industries and Markets Served

Bio-Rad serves the pharmaceutical and biotechnology industries, providing tools for drug discovery and development. Academic and government research labs use Bio-Rad products for basic research in genomics, proteomics, and cell biology. Clinical laboratories (hospital and reference labs) rely on diagnostics for blood banking, diabetes, and infectious disease testing. The food industry leverages Bio-Rad’s food safety testing kits for allergens and pathogens. Environmental testing labs use Bio-Rad’s PCR reagents for water quality monitoring. The company also supports the evolving field of personalized medicine through companion diagnostics.

Leadership and Management Philosophy

Bio-Rad’s leadership team combines deep scientific expertise with business acumen. CEO Norman Schwartz (son of co-founder) fosters a culture of innovation and customer intimacy. The management philosophy emphasizes empowering employees, cross-functional collaboration, and data-driven decision-making. Regular town halls and open-door policies ensure transparency. The company invests heavily in leadership development programs, including mentorship and executive coaching. Strategic decisions are guided by a long-term view rather than quarterly pressures, allowing Bio-Rad to sustain its competitive edge.

Corporate Events, Conferences, and Community Engagement

Bio-Rad actively participates in global conferences such as AACR, ASM, and the AACC Annual Scientific Meeting. The company hosts webinars and workshops on digital PCR and multiplexing. Locally, the Bio-Rad Foundation supports STEM education in underprivileged schools and provides grants for health initiatives. Employees volunteer in community health fairs and blood drives. Bio-Rad also sponsors innovation challenges and collaborates with universities on research projects.

Employees and Workplace Culture

Bio-Rad is recognized as a great place to work due to its focus on work-life balance, professional development, and inclusive culture. Employee benefits include competitive salaries, 401(k) matching, tuition reimbursement, and health/wellness programs. The company promotes internal mobility and offers technical and soft-skills training. Diversity is championed through employee resource groups for women, minorities, and veterans. The workplace environment is collaborative, with open office layouts and cafeteria spaces encouraging interaction. Remote and flexible work arrangements exist for eligible roles.

Job Details & Requirements for this Posting

Role: Senior Research Scientist – Clinical Diagnostics
Location: Hercules, CA (onsite)
Job Type: Full-time

Responsibilities: Lead research projects to develop novel diagnostic assays and reagents; design and execute experiments using molecular biology and immunoassay techniques; analyze data and present findings to cross-functional teams; collaborate with product management and manufacturing to transfer technologies; contribute to intellectual property filings.

Qualifications: PhD in Biochemistry, Molecular Biology, or related field with 5+ years of industry experience; hands-on expertise in PCR, ELISA, and assay development; knowledge of FDA/ISO 13485 guidelines; strong publication record; excellent communication skills.

Why Join: Be part of a company with a 70+ year legacy of innovation; work on products that directly impact patient health; access to state-of-the-art labs; competitive compensation and comprehensive benefits; career growth in a stable, global organization.

Customer Reviews and Industry Reputation

Glassdoor

Bio-Rad on Glassdoor holds a 4.1/5 rating based on thousands of reviews. Employees praise the collaborative culture, interesting work, and good work-life balance. Cons include bureaucracy and occasional slow decision-making. Many highlight strong benefits and job security.

Indeed

Indeed reviews average 3.9/5. Positive comments focus on supportive managers and meaningful work in life sciences. Negative feedback cites limited career advancement in some departments.

Gartner Peer Insights

Bio-Rad scores 4.3/5 as a vendor. Customers appreciate the reliability of instruments and high level of technical support. Some note that software interfaces could be more intuitive.

Trustpilot

On Trustpilot, Bio-Rad has mixed reviews (3.2/5). Researchers mention good product quality but occasional shipping delays for reagents.

G2

G2 ratings for Bio-Rad’s software (e.g., CFG Manager) are around 4.0/5. Users like the functionality but desire more integrations.

Google Reviews

Google reviews of Bio-Rad products and services average 4.0 stars. Customers highlight the educational webinars and responsive service.

LinkedIn Reputation

LinkedIn profiles of Bio-Rad show strong employer brand with frequent posts about innovation and community impact. The company has 300k+ followers and high engagement.

Overall, Bio-Rad enjoys a solid reputation as a trusted partner in life sciences and diagnostics. While no company is perfect, the consistent focus on quality and customer support earns respect across the industry.

Why Organizations Choose Bio-Rad Laboratories, Inc.

Organizations choose Bio-Rad for its proven track record of reliable products, extensive technical support, and commitment to innovation. The company’s global footprint ensures local service and fast delivery. Compliance with stringent regulatory standards gives confidence in data integrity. Additionally, Bio-Rad’s open architecture allows integration with other lab systems, reducing operational friction. Partnerships with Bio-Rad also provide access to cutting-edge technologies such as digital PCR, which is crucial for precision medicine research.

Official Contact Information

For inquiries and assistance, please reach out to Bio-Rad Laboratories, Inc. using the following contact details:

Address: 1000 Alfred Nobel Drive, Hercules, CA 94547, USA
Contact Number: +1 (800) 424-6723
Support Number: +1 (510) 741-1000
Helpdesk Number: +1 (800) 225-4357
Website: www.bio-rad.com

Official Social Media Presence

Follow Bio-Rad on LinkedIn, Twitter (@BioRadLabs), Facebook, and YouTube for the latest updates on products, research breakthroughs, and career opportunities.

SEO FAQ Section

Bio-Rad Laboratories, Inc. is known for its innovative life science research tools and clinical diagnostic solutions, including digital PCR systems and blood typing reagents.

Bio-Rad Laboratories, Inc. is headquartered in Hercules, California, USA.

Bio-Rad Laboratories, Inc. was founded in 1952.

The CEO of Bio-Rad Laboratories, Inc. is Norman Schwartz.

Bio-Rad Laboratories, Inc. employs over 8,000 people globally.

Key products include the QX200 Droplet Digital PCR system, Bio-Plex multiplex immunoassay platforms, and the IH-1000 blood typing analyzer.

Yes, Bio-Rad Laboratories, Inc. scores highly on Glassdoor and Indeed for culture, benefits, and work-life balance.

Bio-Rad Laboratories, Inc. serves life sciences research, clinical diagnostics, food safety, environmental testing, and pharmaceutical development.

Yes, Bio-Rad Laboratories, Inc. offers internships and co-op programs in various technical and business functions.

You can apply through the careers page on Bio-Rad Laboratories, Inc. official website.

Bio-Rad Laboratories, Inc. generates annual revenue of approximately $2.5 to $2.8 billion.

Yes, Bio-Rad Laboratories, Inc. developed and supplies molecular tests for COVID-19 detection.

Core values include integrity, collaboration, customer focus, and continuous improvement.

Manufacturing sites are in USA (California, Maine), Europe (Germany, UK), and Asia (China, Japan).

Yes, Bio-Rad Laboratories, Inc. has set goals to reduce carbon emissions and waste by 2030.

The stock ticker is BIO on the New York Stock Exchange.

Through the Bio-Rad Foundation, the company funds STEM programs and grants for schools.

Bio-Rad Laboratories, Inc. offers 24/7 technical support, online resources, and on-site service engineers.

Recent acquisitions include Exkemia (cell counting) and AbD Serotec (antibodies).

Visit the publications section on Bio-Rad Laboratories, Inc. website or search in scientific databases.

For additional resources and expert insights on guest posting and digital marketing strategies, explore Guest Post Packages available through Bio-Rad Laboratories, Inc. partner networks. These services complement the corporate research ecosystem by amplifying visibility and thought leadership.